LEONARD HARRIS
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
STEVE ANTOLINE, JOSIAH AUSTIN, JOSIAH T. AUSTIN, ALESSANDRO BALDI, TOM CLARK, DANIEL FLYNN, PATRICK GALLAGHER, DAVID HALVERSON, STEVE HARRIS, STANLEY HOSTLER, EDWARD HUGHES, RODERICK JACKSON, GREG KILBY, GREGORY KILBY, STEVE O-LOUGHLIN, MATTHEW POWELL, MILAN PUSKAR, ED ROBERSON, ED ROBERTSON, SCOTT SEGAL, MAGED SHENOUDA, JOHAN (THIJS) M. SPOOR, STEPHEN TURNER, STEPHEN A. TURNER, ANDREW ZULAUF, C. ANDREW ZULAUF
DIRECTOR, EXECUTIVE OFFICER
BLAINE BAILEY, ANGUS CHRISTIE, RYAN DUNFIELD, STEPHAN FITCH, STEPHAN A. FITCH, LEN HARRIS, KEITH HENDERSON, DR. MURRAY HITZMAN, MICHAEL HUNTER, ROBERT KOPPLE, DEEPAK MALHOTRA, PAUL MATYSEK, KAREEN MCKINNON, MARLA RITCHIE, MARLA K. RITCHIE, MARLA K. RITCHIE, STUART ROSS, LAWRENCE W. TALBOT, LAWRENCE W. TALBOT, HENDRICK VAN ALPHEN, HENDRIK VAN ALPHEN, HENK VAN ALPHEN, ROBERT VAN DOORN
DIRECTOR
DIRECTOR
MARCELO A. AWAD, DAVID CROSS, JAMES DAWSON, JAMES M. DAWSON, NEAL GORDON, SEAD HAMZAGIC, SCOTT HEFFERNAN, CESAR JIL, DAVID LIES, PAUL MATYSEK, TIMOTHY MCCUTCHEON, GORDON NEAL, KEVIN NISHI, JEFFREY PONTIUS, MARLA RITCHIE, MARLA K. RITCHIE, MARLA RTICHIE, STEFAN SCHAUSS, MAURICE STRONG, LAWRENCE TALBOT, XIAOHUAN TANG, HENDRIK VAN ALPHEN, HENDRIK (HENK) VAN ALPHEN, HENK VAN ALPHEN, HERK VAN ALPHEN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Debt
2016-05-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2015-08-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Debt
2015-05-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-10-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-04-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-04-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-10-25
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-09-25
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-08-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-07-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2013-04-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-12-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2012-11-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-08-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-05-04
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2011-12-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2010-11-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2011-09-02

